Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin
- 1 August 2001
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 45 (2) , 196-207
- https://doi.org/10.1067/mjd.2001.115966
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acneJournal of the American Academy of Dermatology, 2001
- Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial InfarctionCirculation, 1997
- Long-term safety of isotretinoin as a treatment for acne vulgarisBritish Journal of Dermatology, 1994
- Adverse Reactions to Oral Retinoids An UpdateDrug Safety, 1993
- Epidemiology of headache in a general population—A prevalence studyJournal of Clinical Epidemiology, 1991
- Adverse Effects of RetinoidsMedical Toxicology, 1988
- Medical complications of isotretinoinClinics in Dermatology, 1986
- Changes in Plasma Lipids and Lipoproteins during Isotretinoin Therapy for AcneNew England Journal of Medicine, 1985
- Consensus conference: Treatment of hypertriglyceridemiaJAMA, 1984
- Isotretinoin therapy for acne: Results of a multicenter dose-response studyJournal of the American Academy of Dermatology, 1984